NEDC is dedicated to developing and implementing a nationally consistent, evidence-based system of care for the prevention and treatment of eating disorders.
Read moreThis Information Sheet was developed by Eating Disorders Neurodiversity Australia.
Read moreGlucagon-like peptide-1receptor agonists (GLP-1 RAs), such as semaglutide (Ozempic), are medications originally developed to treat type 2 diabetes.
Read more